Cargando…

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is one of the most common childhood psychiatric disorders and negatively impacts caregivers’ lives. Factors including barriers to accessing care, dissatisfaction with support services, and lack of caregiver resources may contribute to this....

Descripción completa

Detalles Bibliográficos
Autores principales: Fridman, Moshe, Banaschewski, Tobias, Sikirica, Vanja, Quintero, Javier, Chen, Kristina S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384740/
https://www.ncbi.nlm.nih.gov/pubmed/28408828
http://dx.doi.org/10.2147/NDT.S128752
_version_ 1782520494698790912
author Fridman, Moshe
Banaschewski, Tobias
Sikirica, Vanja
Quintero, Javier
Chen, Kristina S
author_facet Fridman, Moshe
Banaschewski, Tobias
Sikirica, Vanja
Quintero, Javier
Chen, Kristina S
author_sort Fridman, Moshe
collection PubMed
description BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is one of the most common childhood psychiatric disorders and negatively impacts caregivers’ lives. Factors including barriers to accessing care, dissatisfaction with support services, and lack of caregiver resources may contribute to this. OBJECTIVES: To report caregivers’ experiences of ADHD diagnosis, behavioral therapy (BT), and supportive care for children/adolescents with ADHD. METHODS: The Caregiver Perspective on Pediatric ADHD (CAPPA) survey included caregivers of children/adolescents (6–17 years) from ten European countries who were currently receiving/had received ADHD pharmacotherapy in the previous 6 months. Caregivers reported experiences of obtaining an ADHD diagnosis, access to BT, availability of caregiver resources, and level of health care/school support. Pan-EU and country-specific descriptive statistics are reported; responses were compared across countries. RESULTS: Of 3,616 caregivers, 66% were female. Mean age of children/adolescents was 11.5 years; 80% were male. Mean time from the first doctor visit to diagnosis was 10.8 (95% confidence interval 10.2, 11.3) months; 31% of caregivers reported the greatest degrees of difficulty in obtaining an ADHD diagnosis; 44% of children/adolescents did not receive BT. Forty-seven percent of caregivers reported that sufficient resources were available, 44% were “very satisfied”/“satisfied” with medical care, and 50% found health care providers “very supportive”/“somewhat supportive”. Mainstream schools were attended by 82% of children/adolescents. Of those, 67% of caregivers thought schools could help more with the child/adolescent’s ADHD and 48% received extra help/special arrangement. Results varied significantly between countries (P<0.001, all parameters). CONCLUSION: Almost a third of caregivers reported a high degree of difficulty in obtaining an ADHD diagnosis for their child/adolescent, less than half felt that sufficient resources were available, and gaps in support from health care providers/schools were identified. Findings underscore the need to improve access to diagnosis and provision of supportive services to enable better standards of care, and potentially reduce the impact of child/adolescent ADHD on caregivers’ lives.
format Online
Article
Text
id pubmed-5384740
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53847402017-04-13 Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey Fridman, Moshe Banaschewski, Tobias Sikirica, Vanja Quintero, Javier Chen, Kristina S Neuropsychiatr Dis Treat Original Research BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is one of the most common childhood psychiatric disorders and negatively impacts caregivers’ lives. Factors including barriers to accessing care, dissatisfaction with support services, and lack of caregiver resources may contribute to this. OBJECTIVES: To report caregivers’ experiences of ADHD diagnosis, behavioral therapy (BT), and supportive care for children/adolescents with ADHD. METHODS: The Caregiver Perspective on Pediatric ADHD (CAPPA) survey included caregivers of children/adolescents (6–17 years) from ten European countries who were currently receiving/had received ADHD pharmacotherapy in the previous 6 months. Caregivers reported experiences of obtaining an ADHD diagnosis, access to BT, availability of caregiver resources, and level of health care/school support. Pan-EU and country-specific descriptive statistics are reported; responses were compared across countries. RESULTS: Of 3,616 caregivers, 66% were female. Mean age of children/adolescents was 11.5 years; 80% were male. Mean time from the first doctor visit to diagnosis was 10.8 (95% confidence interval 10.2, 11.3) months; 31% of caregivers reported the greatest degrees of difficulty in obtaining an ADHD diagnosis; 44% of children/adolescents did not receive BT. Forty-seven percent of caregivers reported that sufficient resources were available, 44% were “very satisfied”/“satisfied” with medical care, and 50% found health care providers “very supportive”/“somewhat supportive”. Mainstream schools were attended by 82% of children/adolescents. Of those, 67% of caregivers thought schools could help more with the child/adolescent’s ADHD and 48% received extra help/special arrangement. Results varied significantly between countries (P<0.001, all parameters). CONCLUSION: Almost a third of caregivers reported a high degree of difficulty in obtaining an ADHD diagnosis for their child/adolescent, less than half felt that sufficient resources were available, and gaps in support from health care providers/schools were identified. Findings underscore the need to improve access to diagnosis and provision of supportive services to enable better standards of care, and potentially reduce the impact of child/adolescent ADHD on caregivers’ lives. Dove Medical Press 2017-03-30 /pmc/articles/PMC5384740/ /pubmed/28408828 http://dx.doi.org/10.2147/NDT.S128752 Text en © 2017 Fridman et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Fridman, Moshe
Banaschewski, Tobias
Sikirica, Vanja
Quintero, Javier
Chen, Kristina S
Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
title Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
title_full Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
title_fullStr Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
title_full_unstemmed Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
title_short Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
title_sort access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with adhd in europe: data from the caregiver perspective on pediatric adhd survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384740/
https://www.ncbi.nlm.nih.gov/pubmed/28408828
http://dx.doi.org/10.2147/NDT.S128752
work_keys_str_mv AT fridmanmoshe accesstodiagnosistreatmentandsupportiveservicesamongpharmacotherapytreatedchildrenadolescentswithadhdineuropedatafromthecaregiverperspectiveonpediatricadhdsurvey
AT banaschewskitobias accesstodiagnosistreatmentandsupportiveservicesamongpharmacotherapytreatedchildrenadolescentswithadhdineuropedatafromthecaregiverperspectiveonpediatricadhdsurvey
AT sikiricavanja accesstodiagnosistreatmentandsupportiveservicesamongpharmacotherapytreatedchildrenadolescentswithadhdineuropedatafromthecaregiverperspectiveonpediatricadhdsurvey
AT quinterojavier accesstodiagnosistreatmentandsupportiveservicesamongpharmacotherapytreatedchildrenadolescentswithadhdineuropedatafromthecaregiverperspectiveonpediatricadhdsurvey
AT chenkristinas accesstodiagnosistreatmentandsupportiveservicesamongpharmacotherapytreatedchildrenadolescentswithadhdineuropedatafromthecaregiverperspectiveonpediatricadhdsurvey